2012 IW 1000 Company Profile

AstraZeneca PLC
Pharmaceuticals
United States
2012 IW 1000 Rank:
Current Rank : 131
Prior Rank : 119
Executive 1 : Mr. David Brennan, Chief Executive Officer
Executive 2 : Mr. Simon Lowth, Chief Financial Officer
131 of 1000
Earnings Per Share Growth (%)31.06%
Cost of Goods Sold (US$ Millions)$6,026
Current Liabilities (US$ Millions)$15,752
Total Assets (US$ Millions)$23,506
Long Term Debt7338
Return on Equity43.15
Market Capitalization (US$ Millions)$59,823
Price to Earnings Ratio7.15
Revenue (US$ Millions)$34,427
Total Company Assets$52,830
Revenue Growth (%)0.96%
Net Income (US$ Millions)$10,016
Earnings Per Share (US$)$7.30
Total Equity (US$ Millions)$23,246
Profit Margin (%)29.09%
Debt To Equity Ratio (%)0.32%
Inventory Turnover1852

Subscribe to IW Newsletters

IW Marketplace - Buy a Link Now